Select Medical Sees FY23 Adj. EPS $1.86-$2.03 vs $1.94 Est., Revenue $6.55B-$6.7B vs $6.59B Est.
Portfolio Pulse from Benzinga Newsdesk
Select Medical has provided its FY23 guidance, expecting adjusted EPS to be between $1.86 and $2.03, compared to the estimated $1.94. The company also anticipates revenue to be between $6.55 billion and $6.7 billion, versus the estimated $6.59 billion.
August 04, 2023 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Select Medical's FY23 guidance is slightly above estimates. This could potentially have a positive impact on the company's stock price.
Select Medical's FY23 guidance for both EPS and revenue is slightly above the estimates. This indicates that the company is performing well and could potentially exceed investor expectations, which could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100